Galderma, a leading global dermatology company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1981, Galderma has established itself as a pioneer in the field of medical and aesthetic dermatology, focusing on innovative solutions for skin health. The company is renowned for its core products, including the Restylane® range of dermal fillers and the Sculptra® aesthetic treatment, which are distinguished by their unique formulations and proven efficacy. Galderma's commitment to research and development has positioned it as a trusted name in the industry, with a strong market presence and notable achievements in advancing dermatological care. With a focus on enhancing skin health and beauty, Galderma continues to lead the way in dermatological innovation.
How does Galderma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Galderma's score of 32 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Galderma, headquartered in the US, currently does not have publicly available carbon emissions data, as indicated by the absence of specific figures for emissions in kg CO2e. The company is a current subsidiary of Galderma Laboratories, L.P., and emissions data may be cascaded from its parent organisation, Galderma Group AG, at a cascade level of three. Despite the lack of specific emissions data, Galderma has not outlined any formal reduction targets or climate pledges. This absence of documented initiatives suggests that the company may still be in the early stages of developing its climate strategy. As part of the broader industry context, many companies are increasingly committing to science-based targets and sustainability initiatives, which may influence Galderma's future climate commitments. However, without specific data or targets, it is challenging to assess their current climate impact or future direction in emissions reduction.
Access structured emissions data, company-specific emission factors, and source documents
2022 | 2023 | |
---|---|---|
Scope 1 | - | 0,000,000 |
Scope 2 | 5,600,000 | 0,000,000 |
Scope 3 | - | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Galderma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.